Elementary: Breast Cancer Culprits Leave Their Signatures on the Double Helix

Overview

Journal Cell Death Differ

Specialty Cell Biology

Date 2016 Sep 3

PMID 27588706

Authors

Delphine Merino

Bhupinder Pal

Anthony T Papenfuss

Affiliations

Soon will be listed here.

References

Fournier G, Cabaud O, Josselin E, Chaix A, Adelaide J, Isnardon D . Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth. Oncogene. 2011; 30(36):3862-74. DOI: 10.1038/onc.2011.106. View

Weinhold N, Jacobsen A, Schultz N, Sander C, Lee W . Genome-wide analysis of noncoding regulatory mutations in cancer. Nat Genet. 2014; 46(11):1160-5. PMC: 4217527. DOI: 10.1038/ng.3101. View

Katoh M, Igarashi M, Fukuda H, Nakagama H, Katoh M . Cancer genetics and genomics of human FOX family genes. Cancer Lett. 2012; 328(2):198-206. DOI: 10.1016/j.canlet.2012.09.017. View

Perera D, Poulos R, Shah A, Beck D, Pimanda J, Wong J . Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes. Nature. 2016; 532(7598):259-63. DOI: 10.1038/nature17437. View

Lawrence M, Stojanov P, Mermel C, Robinson J, Garraway L, Golub T . Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014; 505(7484):495-501. PMC: 4048962. DOI: 10.1038/nature12912. View

Ali H, Rueda O, Chin S, Curtis C, Dunning M, Aparicio S . Genome-driven integrated classification of breast cancer validated in over 7,500 samples. Genome Biol. 2014; 15(8):431. PMC: 4166472. DOI: 10.1186/s13059-014-0431-1. View

Chen X, Iliopoulos D, Zhang Q, Tang Q, Greenblatt M, Hatziapostolou M . XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway. Nature. 2014; 508(7494):103-107. PMC: 4105133. DOI: 10.1038/nature13119. View

Horn S, Figl A, Rachakonda P, Fischer C, Sucker A, Gast A . TERT promoter mutations in familial and sporadic melanoma. Science. 2013; 339(6122):959-61. DOI: 10.1126/science.1230062. View

Alexandrov L, Nik-Zainal S, Wedge D, Aparicio S, Behjati S, Biankin A . Signatures of mutational processes in human cancer. Nature. 2013; 500(7463):415-21. PMC: 3776390. DOI: 10.1038/nature12477. View

10.

Nik-Zainal S, Alexandrov L, Wedge D, Van Loo P, Greenman C, Raine K . Mutational processes molding the genomes of 21 breast cancers. Cell. 2012; 149(5):979-93. PMC: 3414841. DOI: 10.1016/j.cell.2012.04.024. View

11.

Curtis C, Shah S, Chin S, Turashvili G, Rueda O, Dunning M . The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012; 486(7403):346-52. PMC: 3440846. DOI: 10.1038/nature10983. View

12.

Huang F, Hodis E, Xu M, Kryukov G, Chin L, Garraway L . Highly recurrent TERT promoter mutations in human melanoma. Science. 2013; 339(6122):957-9. PMC: 4423787. DOI: 10.1126/science.1229259. View

13.

Morganella S, Alexandrov L, Glodzik D, Zou X, Davies H, Staaf J . The topography of mutational processes in breast cancer genomes. Nat Commun. 2016; 7:11383. PMC: 5001788. DOI: 10.1038/ncomms11383. View

14.

Pennanen P, Sarvilinna N, Purmonen S, Ylikomi T . Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell.... Steroids. 2009; 74(4-5):404-9. DOI: 10.1016/j.steroids.2008.12.005. View